Archives

Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules

B CRANFORD, N.J., April 24, 2026 /PRNewswire/ — Citius Pharmaceuticals Inc. (Nasdaq: CTXR) (“Citius Pharma” or the “Company”), a biopharmaceutical company dedicated to the development… Login to continue reading Login…

Read MoreCitius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules

Daewoong Pharmaceutical Hosts ‘NABOTA Master Class’… Highlighting Safety Amid Growing Demand for High-Dose, Repetitive Treatments

B 74 healthcare professionals from 13 countries attended, recognizing the value of PrabotulinumtoxinA’s “Safety” Comprehensive program including anatomy sessions, proprietary injection techniques, and 1:1 hands-on… Login to continue reading Login…

Read MoreDaewoong Pharmaceutical Hosts ‘NABOTA Master Class’… Highlighting Safety Amid Growing Demand for High-Dose, Repetitive Treatments